Physician profile
Jeffrey Milles
NPI 1194164244
$4,942.35
in general payments reported to CMS, 2019-2025
8 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.50 · 2020: $1,002 · 2021: $1,459 · 2022: $1,867 · 2023: $165 · 2024: $24.40 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $422 · Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $421.50 |
| Food and Beverage | $155.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,462.10 | 2020-2025 | Persona Partial Knee System, Avenir, Persona |
| Depuy Synthes Sales INC. | $154.19 | 2021 | |
| Smith+Nephew, INC. | $77.73 | 2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Stryker Corporation | $77.64 | 2019-2020 | |
| Biocomposites INC | $66.08 | 2020 | |
| Heraeus Medical, LLC. | $53.11 | 2025 | |
| Pacira Therapeutics, INC. | $27.10 | 2020 | |
| Elite Orthopedics, LLC | $24.40 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Milles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.